Tylenol on the Spectrum: Investigating the Autism Link
Listen now
Description
On this week's episode of the pod, we'll walk through a study together! Jess leads a journal club session, diving deep into a study about the potential link between prenatal Tylenol use and signs of Autism Spectrum Disorder (measured using language assessments). She shares her approach to understanding research and breaks down a specific study, highlighting crucial elements like research design, sample selection, and how comparison groups are created. Jess analyzes the results, explains the statistics, and examines the study's strengths and limitations. Finally, she sums up the key takeaways and what they mean for future research. This episode is a must-listen for anyone interested in research methods or curious about this topic! All our sources from this episode are available at: https://www.unbiasedscipod.com/episodes/acetaminophen-autism-connection (00:00) Intro and Farewell to Dr. Andrea Love (02:54) Journal Club: Acetaminophen and Autism Spectrum Disorder (03:20) Understanding Autism Spectrum Disorder (08:45) The Relationship Between Tylenol and Autism Spectrum Disorder (09:36) Safety Concerns and Observational Studies (10:35) Causality and Study Design (12:50) Confounding Variables and Observational Studies (14:30) Study: Examining the Relationship of Acetaminophen Use During Pregnancy with Early Language Development in Children (15:54) Reading a Study: Study Design and Statistical Analysis (21:52) How Participants Were Recruited For The Study (24:20) Assessing Language (26:10) Other Variables and Adjustment Factors Considered (28:15) Statistical Analysis (31:20) Study Population and Sample Size (34:17) Comparison of Acetaminophen Users and Non-Users (40:45) Measure of Effect, Odds Ratios, p-Values and Null Values (46:23) Strengths and Limitations of the Study (49:07) Summary and Final Thoughts Interested in advertising with us? Please reach out to [email protected], with “Unbiased Science” in the subject line. PLEASE NOTE: The discussion and information provided in this podcast are for general educational, scientific, and informational purposes only and are not intended as, and should not be treated as, medical or other professional advice for any particular individual or individuals. Every person and medical issue is different, and diagnosis and treatment requires consideration of specific facts often unique to the individual. As such, the information contained in this podcast should not be used as a substitute for consultation with and/or treatment by a doctor or other medical professional. If you are experiencing any medical issue or have any medical concern, you should consult with a doctor or other medical professional. Further, due to the inherent limitations of a podcast such as this as well as ongoing scientific developments, we do not guarantee the completeness or accuracy of the information or analysis provided in this podcast, although, of course we always endeavor to provide comprehensive information and analysis. In no event may Unbiased Science or any of the participants in this podcast be held liable to the listener or anyone else for any decision allegedly made or action allegedly taken or not taken allegedly in reliance on the discussion or information in this podcast or for any damages allegedly resulting from such reliance. The information provided herein do not represent the views of our employers. Learn more about your ad choices. Visit megaphone.fm/adchoices
More Episodes
In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman discuss the complexities of cancer with Dr. Joe Zundell, a cancer biologist. They explore the definition of cancer, its prevalence, and the hallmarks that characterize cancer cells. The conversation delves into the mechanisms of cancer...
Published 11/20/24
In this episode, Dr. Jessica Steier and Dr. Sarah Scheinman welcome Dr. Namandjé Bumpus, Principal Deputy Commissioner of the FDA, who shares insights into the agency's operations and her path from academia to FDA leadership. The scientists explore the complexities of drug approval processes, the...
Published 11/13/24
Published 11/13/24